Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works

Holly Fernandez Lynch of the Perelman School of Medicine says that lowered FDA standards send a message to the drug industry that they don’t have to prove their medication works.

・ From Associated Press